糖皮质激素联合羟氯喹治疗系统性红斑狼疮皮疹的临床效果

摘要
图/表
参考文献(16)
相关文章 (15)

全文: PDF (592 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的分析和评价糖皮质激素联合羟氯喹治疗系统性红斑狼疮皮疹的临床效果。方法选取2020年1月至12月上饶市人民医院收治的60 例系统性红斑狼疮皮疹患者作为研究对象，患者均为女性。按照入院顺序单双号分为对照组和研究组，每组30 例，对照组采取单一的糖皮质激素进行治疗，研究组采取糖皮质激素联合羟氯喹的方式进行治疗，比较两组的红斑狼疮活动度、炎症指标红细胞沉降率水平、C3 补体、康复总有效率以及不良反应发生情况。结果研究组红斑狼疮活动度和炎症指标红细胞沉降率水平低于对照组，C3 补体水平高于对照组，差异有统计学意义（P＜0.05）；研究组的康复总有效率高于对照组，差异有统计学意义（P＜0.05）；研究组胃肠道反应、白细胞轻度降低、头晕不适的发生率均低于对照组，差异有统计学意义（P＜0.05）。结论应用糖皮质激素联合羟氯喹治疗系统性红斑狼疮皮疹，能够有效降低红斑狼疮活动评分和炎症指标红细胞沉降率水平，有效提升C3 补体水平，而且能够显著提升临床治疗总有效率，降低各项不良反应的发生，可以在该病的临床治疗中广泛使用。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	胡珊

关键词 ：糖皮质激素, 羟氯喹, 红斑狼疮, 皮疹, 应用效果

Abstract：Objective To analyze and evaluate the clinical effect of Glucocorticoid combined with Hydroxychloroquine in the treatment of systemic lupus erythematosus rash. Methods A total of 60 patients with systemic lupus erythematosus rash admitted to Shangrao City People's Hospital from January to December 2020 were selected as the research objects. The patients were all female. According to the order of admission，single and double numbers were divided into control group and study group，each with 30 cases. The control group was treated with a single Glucocorticoid，and the study group used Glucocorticoid combined with Hydroxychloroquine for treatment，the lupus erythematosus activity，inflammatory index erythrocyte sedimentation rate，C3 complement，total effective rate of rehabilitation，and occurrence of adverse reactions between the two groups were compared. Results The lupus erythematosus activity and inflammatory index erythrocyte sedimentation rate of the study group were lower than those of the control group，and the C3 complement level was higher than that of the control group，and the differences were significant (P＜0.05). The total effective rate of rehabilitation of the study group was higher than that of the control group，and the difference was significant (P＜0.05). The incidence of gastrointestinal reactions，mild white blood cell reduction，dizziness and discomfort in the study group were lower than those in the control group，and the differences were significant (P＜0.05). Conclusion The application of Glucocorticoids combined with Hydroxychloroquine in the treatment of systemic lupus erythematosus rash can effectively reduce the lupus erythematosus activity score and inflammatory index erythrocyte sedimentation rate，effectively increase the level of C3 complement，and can significantly improve the total effective rate of clinical treatment and reduce various adverse effects The occurrence of reaction，the clinical effect of this treatment method is significant，and it can be widely used in the clinical treatment of the disease.

Key words： Glucocorticoid； Hydroxychloroquine； Lupus erythematosus； Rash； Application effect

收稿日期: 2021-04-21

基金资助:江西省卫生健康委科技计划项目（SKJP202141026）

引用本文:

胡珊. 糖皮质激素联合羟氯喹治疗系统性红斑狼疮皮疹的临床效果[J]. 中国当代医药, 2022, 29(1): 36-38.
HU Shan. Clinical effect of Glucocorticoid combined with Hydroxychloroquine in the treatment of systemic lupus erythematosus rash. 中国当代医药, 2022, 29(1): 36-38.

链接本文:

http://dangdaiyiyao.com/CN/ 或 http://dangdaiyiyao.com/CN/Y2022/V29/I1/36

[1]	佘应淑.糖皮质激素联合羟氯喹对系统性红斑狼疮皮疹患者的疗效观察[J].医学信息，2017，30（21）：73-74.
[2]	徐玲，舒畅，范中光.糖皮质激素联合羟氯喹治疗系统性红斑狼疮皮疹康复的疗效观察[J].反射疗法与康复医学，2019，29（4）：101-102.
[3]	沈小霞.糖皮质激素联合羟氯喹治疗系统性红斑狼疮皮疹的效果观察[J].中外医学研究，2017，15（10）：107-109.
[4]	钟仕卿，李群苑.甲氨蝶呤治疗系统性红斑狼疮的实验室检查结果及临床疗效分析[J].广州医药，2017，48（2）：92-95.
[5]	Guidelines for referral and management of systemic lupus erythematosus in adults.American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines[M].Arthritis Rheum，1999，42（9） 1785-1796.
[7]	系统性红斑狼疮诊治指南（草案）[A].风湿病中西医结合研究进展[C].{4}：浙江省科学技术协会，2005：9.
[8]	张嵩，谢长好，陈琳洁.女性系统性红斑狼疮合并膝关节骨梗死的临床分析[J].中华全科医学，2019，18（7）：1103-1106.
[9]	李婧，郭春芳，李上云，等.以紫癜为首发皮疹的大疱性系统性红斑狼疮1 例[J].临床皮肤科杂志，2020，49（5）：301-302.
[10]	陈怡雯，苏婷，张美华，等.以皮肤损害为首要表现的巨细胞病毒感染一例[J].中华皮肤科杂志，2019，52（4）：236-240.
[11]	任飞凤，陈林，黄文瀚，等.自身免疫病相关性噬血细胞性淋巴组织细胞增多症16 例临床特征[J].中华临床免疫和变态反应杂志，2019，13（1）：11-16.
[6]	Zappitelli M1，Duffy CM，Bernard C，et al.Evaluationof ctivity，chronicity and tubulointerstitial indices for childhood lupus nephritis[J].Pediatr Nephrol，2008，23（1）：83-91.
[12]	郭丽媛，伊茂礼，吴金英，等.系统性红斑狼疮合并皮疽诺卡菌性肝脓肿一例[J].中华临床感染病杂志，2018，11（1）：61-63.
[13]	熊梦燎，李卉，周文明.皮肌炎和系统性红斑狼疮重叠综合征伴Degos 样皮疹1 例[J].中国皮肤性病学杂志，2020，34（8）：915-917.
[14]	方志旭，蒋莉.儿童系统性红斑狼疮合并视神经脊髓炎谱系疾病一例[J].国际儿科学杂志，2019，46（7）：536-538.
[15]	游芳凝，李琦晖.氢氯噻嗪致系统性红斑狼疮患者严重过敏反应1 例[J].中国药业，2019，28（9）：84.
[16]	樊剑锋，沈颖.系统性红斑狼疮治疗新方法疗效及评价[J].中国实用儿科杂志，2017，27（9）：663-666.